Aberrant Lipid Metabolism: An Emerging Diagnostic and Therapeutic Target in Ovarian Cancer

por Pyragius, Carmen E., Fuller, Maria, Ricciardelli, Carmela, Oehler, Martin K.
Publicado 2013

Substrate Deprivation Therapy to Reduce Glycosaminoglycan Synthesis Improves Aspects of Neurological and Skeletal Pathology in MPS I Mice

por Derrick-Roberts, Ainslie L. K., Jackson, Matilda R., Pyragius, Carmen E., Byers, Sharon
Publicado 2017

Chemotherapy-induced hyaluronan production: a novel chemoresistance mechanism in ovarian cancer

por Ricciardelli, Carmela, Ween, Miranda P, Lokman, Noor A, Tan, Izza A, Pyragius, Carmen E, Oehler, Martin K
Publicado 2013

Annexin A2 is regulated by ovarian cancer-peritoneal cell interactions and promotes metastasis

por Lokman, Noor A., Elder, Alison SF., Ween, Miranda P., Pyragius, Carmen E., Hoffmann, Peter, Oehler, Martin K., Ricciardelli, Carmela
Publicado 2013

Keratin 5 overexpression is associated with serous ovarian cancer recurrence and chemotherapy resistance

por Ricciardelli, Carmela, Lokman, Noor A., Pyragius, Carmen E., Ween, Miranda P., Macpherson, Anne M., Ruszkiewicz, Andrew, Hoffmann, Peter, Oehler, Martin K.
Publicado 2017